Browse > Article
http://dx.doi.org/10.4014/jmb.1801.01074

Improved Anti-Cancer Effect of Curcumin on Breast Cancer Cells by Increasing the Activity of Natural Killer Cells  

Lee, Hwan Hee (College of Pharmacy, Duksung Women's University)
Cho, Hyosun (College of Pharmacy, Duksung Women's University)
Publication Information
Journal of Microbiology and Biotechnology / v.28, no.6, 2018 , pp. 874-882 More about this Journal
Abstract
Curcumin is known to possess various biological functions, including anti-inflammatory, anti-oxidative, and anti-cancer activities. Natural killer (NK) cells are large lymphocytes that directly kill cancer cells. However, many aggressive cancers, including breast cancer, were reported to escape the successful killing of NK cells in a tumor microenvironment. In this study, we investigated the anti-cancer effect of curcumin in coculture of human breast carcinoma MDA-MB-231 and NK (NK-92) cells. We found that curcumin had an immune-stimulatory effect on NK-92 by increasing the surface expression of the $CD16^+$ and $CD56^{dim}$ population of NK-92. We confirmed that the cytotoxic effect of NK-92 on MDA-MB-231 was significantly enhanced in the presence of curcumin, which was highly associated with the activation of Stat4 and Stat5 proteins in NK-92. Finally, this improved anticancer effect of curcumin was correlated with decreased expression of pErk and PI3K in MDA-MB-231.
Keywords
Curcumin; breast cancer; MDA-MB-231; natural killer cells;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Cooper MA, Fehniger TA, Caligiuri MA. 2001. The biology of human natural killer-cell subsets. Trends Immunol. 22: 633-640.   DOI
2 Ferlazzo G, Thomas D, Lin SL, Goodman K, Morandi B, Muller WA, et al. 2004. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 172: 1455-1462.   DOI
3 Sinha D, Biswas J, Sung B, Aggarwal BB, Bishayee A. 2012. Chemopreventive and chemotherapeutic potential of curcumin in breast cancer. Curr. Drug Targets 13: 1799-1819.   DOI
4 Bengmark S, Mesa MD, Gil A. 2009. Plant-derived health: the effects of turmeric and curcuminoids. Nutr. Hosp. 24: 273-281.
5 Jurenka JS. 2009. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern. Med. Rev. 14: 141-153.
6 Hussain Z, Thu HE, Amjad MW, Hussain F, Ahmed TA, Khan S. 2017. Exploring recent developments to improve antioxidant, anti-inflammatory and antimicrobial efficacy of curcumin: a sreview of new trends and future perspectives. Mater. Sci. Eng. C Mater. Biol. Appl. 77: 1316-1326.   DOI
7 Jin H, Qiao F, Wang Y, Xu Y, Shang Y. 2015. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway. Oncol. Rep. 34: 2782-2789.   DOI
8 Wu J, Lu WY, Cui LL. 2015. Inhibitory effect of curcumin on invasion of skin squamous cell carcinoma A431 cells. Asian Pac. J. Cancer Prev. 16: 2813-2818.   DOI
9 Sui Q, Zhang J, Sun X, Zhang C, Han Q, Tian Z. 2014. NK cells are the crucial antitumor mediators when STAT3- mediated immunosuppression is blocked in hepatocellular carcinoma. J. Immunol. 193: 2016-2023.   DOI
10 Corno C, Gatti L, Lanzi C, Zaffaroni N, Colombo D, Perego P. 2016. Role of the receptor tyrosine kinase Axl and its targeting in cancer cells. Curr. Med. Chem. 23: 1496-1512.   DOI
11 Devarajan E, Huang S. 2009. STAT3 as a central regulator of tumor metastases. Curr. Mol. Med. 9: 626-633.   DOI
12 Chiu TL, Su CC. 2009. Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-kappaBp65 expression in breast cancer MDA-MB-231 cells. Int. J. Mol. Med. 23: 469-475.
13 Lee HH, Kang H, Cho H. 2017. Natural killer cells and tumor metastasis. Arch. Pharm. Res. 40: 1037-1049.   DOI
14 Zhang HG, Kim H, Liu C, Yu S, Wang J, Grizzl e WE, et al. 2007. Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity. Biochim. Biophys. Acta 1773: 1116-1123.   DOI
15 Trivedi M K, M ondal SC, G angwar M , Jana S. 2017. Immunomodulatory potential of nanocurcumin-based formulation. Inflammopharmacology 25: 609-619.   DOI
16 Gottardt D, Sexl V. 2017. STATs in NK-cells: the good, the bad, and the ugly. Front. Immunol. 7: 694.
17 Pires BRB, Silva R, Ferreira GM, Abdelhay E. 2018. NFkappaB: two sides of the same coin. Genes (Basel) 9: E24.   DOI
18 Guan F, Ding Y, Zhang Y, Zhou Y, Li M, Wang C. 2016. Curcumin suppresses proliferation and migration of MDAMB- 231 breast cancer cells through autophagy-dependent Akt degradation. PLoS One 11: e0146553.   DOI
19 Jia T, Zhang L, Duan Y, Zhang M, Wang G, Zhang J, et al. 2014. The differential susceptibilities of MCF-7 and MDA-MB- 231 cells to the cytotoxic effects of curcumin are associated with the PI3K/Akt-SKP2-Cip/Kips pathway. Cancer Cell Int. 14: 126.   DOI
20 Romagnani C, Juelke K, Falco M, Morandi B, D'Agostino A, Costa R, et al. 2007. CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J. Immunol. 178: 4947-4955.   DOI
21 Castriconi R, Cantoni C, Della Chiesa M, Vitale M, Marcenaro E, Conte R, et al. 2003. Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc. Natl. Acad. Sci. USA 100: 4120-4125.   DOI
22 Liu Q, Sun Y, Rihn S, Nolting A, Tsoukas PN, Jost S, et al. 2009. Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection. J. Virol. 83: 8705-8712.   DOI
23 Hoechst B, Voigtlaender T, Ormandy L, Gamrekelashvili J, Zhao F, Wedemeyer H, et al. 2009. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology 50: 799-807.   DOI
24 Balsamo M, Scordamaglia F, Pietra G, Manzini C, Cantoni C, Boitano M, et al. 2009. Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity. Proc. Natl. Acad. Sci. USA 106: 20847-20852.   DOI
25 Bhaumik S, Jyothi MD, Khar A. 2000. Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells. FEBS Lett. 483: 78-82.   DOI
26 Liu Y, Zhou J, Hu Y, Wang J, Yuan C. 2017. Curcumin inhibits growth of human breast cancer cells through demethylation of DLC1 promoter. Mol. Cell. Biochem. 425: 47-58.   DOI
27 Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. 2015. Global cancer statistics. CA Cancer J. Clin. 65: 87-108.   DOI
28 Liu Q, Loo WT, Sze SC, Tong Y. 2009. Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFkappaB, cyclinD and MMP-1 transcription. Phytomedicine 16: 916-922.   DOI
29 Lv ZD, Liu XP, Zhao WJ, Dong Q, Li FN, Wang HB, et al. 2014. Curcumin induces apoptosis in breast cancer cells and inhibits tumor growth in vitro and in vivo. Int. J. Clin. Exp. Pathol. 7: 2818-2824.
30 Banik U, Parasuraman S, Adhikary AK, Othman NH. 2017. Curcumin: the spicy modulator of breast carcinogenesis. J. Exp. Clin. Cancer Res. 36: 98.   DOI
31 Doherty D G, O'Farrelyl C. 2000. Innate a nd a daptive lymphoid cells in the human liver. Immunol. Rev. 174: 5-20.   DOI
32 Joyce JA, Pollard JW. 2009. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9: 239-252.   DOI
33 Zhao Z, Li C, Xi H, Gao Y, Xu D. 2015. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway. Mol. Med. Rep. 12: 5415-5422.   DOI
34 Fiala M. 2015. Curcumin and omega-3 fatty acids enhance NK cell-induced apoptosis of pancreatic cancer cells but curcumin inhibits interferon-gamma production: benefits of omega-3 with curcumin against cancer. Molecules 20: 3020-3026.   DOI
35 Lee HH, Kang H, Cho H. 2017. Recovery of NK(CD56+CD3-) cells after one year of tenofovir therapy for chronic hepatitis B infection. J. Microbiol. Biotechnol. 27: 1204-1308.   DOI